Composition: Bortezomib 3.5mg
Availability of this product will assure once the Pharmacy partners is confirmed.
Bortrac 3.5mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma.
Bortrac 3.5mg injection is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in a number of proteins in the cancer cells leading to their death.
Reduced blood platelets, Fatigue, Peripheral neuropathy (tingling and numbness of feet and hand), Psychiatric disturbances, Nausea, Vomiting, Loss of appetite, Fever, Anemia, Diarrhoea, Decreased appetite, Decreased white blood cell count (neutrophils), Constipation